These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22117156)

  • 1. Surgical management of large renal tumors.
    Vourganti S; Shuch B; Bratslavsky G
    Expert Rev Anticancer Ther; 2011 Dec; 11(12):1889-900. PubMed ID: 22117156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V; Matin SF; Wood CG
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
    Uzzo RG; Novick AC
    J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open surgical partial nephrectomy.
    Ghavamian R; Zincke H
    Semin Urol Oncol; 2001 May; 19(2):103-13. PubMed ID: 11354530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic partial nephrectomy in the treatment of renal cell carcinoma: a minimally invasive means to nephron preservation.
    Blitstein J; Ghavamian R
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):921-7. PubMed ID: 18533801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing concepts in the surgical management of renal cell carcinoma.
    Lam JS; Shvarts O; Pantuck AJ
    Eur Urol; 2004 Jun; 45(6):692-705. PubMed ID: 15149740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the indications for laparoscopic radical nephrectomy.
    Mattar K; Finelli A
    Curr Opin Urol; 2007 Mar; 17(2):88-92. PubMed ID: 17285016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
    Hafez KS; Novick AC; Butler BP
    J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic radical nephrectomy: long-term outcomes.
    Borin JF
    Curr Opin Urol; 2008 Mar; 18(2):139-44. PubMed ID: 18303533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in nephron-sparing surgery for renal cell carcinoma].
    Igarashi T; Tobe T; Ito H
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1726-31. PubMed ID: 12402421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of large renal tumors.
    Wszolek MF; Wotkowicz C; Libertino JA
    Nat Clin Pract Urol; 2008 Jan; 5(1):35-46. PubMed ID: 18185512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
    Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
    Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy.
    Lane BR; Fergany AF; Weight CJ; Campbell SC
    J Urol; 2010 Oct; 184(4):1286-90. PubMed ID: 20723936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].
    Arroua F; Maurin C; Carcenac A; Ragni E; Rossi D; Bastide C
    Prog Urol; 2010 Dec; 20(13):1175-83. PubMed ID: 21130395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of nephron sparing surgery for renal cancer].
    Meyer G; Mullerad M; Nativ O
    Harefuah; 2003 Mar; 142(3):208-11, 237. PubMed ID: 12696476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.